Nicholas Leyland

Hamilton Health Sciences

Papers

3

Total Citations

80

H-Index

3

About

Dr. Nicholas Leyland is a leading figure in minimally invasive gynaecologic surgery, with a research focus on optimizing surgical outcomes for benign conditions such as fibroids and heavy menstrual bleeding. His most influential work, the clinical practice guideline "No. 377-Hysterectomy for Benign Gynaecologic Indications" (2019, 51 citations), provides evidence-based recommendations for surgical decision-making, helping to standardize care and reduce unnecessary interventions. Dr. Leyland has also investigated the impact of preoperative medical therapy on surgical technique, notably in his study on ulipristal acetate and laparoscopic myomectomy (2017, 26 citations), which explored how medication can alter fibroid characteristics and improve operative experience. His contributions extend to the French-language adaptation of his guideline (2019), ensuring broader accessibility. With a career dedicated to advancing surgical safety and patient-centred care, Dr. Leyland’s work has shaped modern approaches to hysterectomy and myomectomy, earning him recognition as a key authority in benign gynaecology.

Research Focus

Key Achievements

3
H-Index
3
Papers
80
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
No. 377-Hysterectomy for Benign Gynaecologic Indications
51 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Hamilton Health Sciences

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago